Treatment Efficacy and Compliance in Patients with Diabetic Macular Edema Treated with Ranibizumab in a Real-Life Setting.

Anne-Laurence BestFranck FajnkuchenSylvia Nghiem-BuffetTyphaine GrenetGabriel QuentelCorinne Delahaye-MazzaSalomon Y CohenAudrey Giocanti-Aurégan

Published in: Journal of ophthalmology (2018)

Our study confirms the real-life efficacy of ranibizumab in DME at M12 and the need for a large number of injections to achieve better visual outcomes. We also showed a trend to a lower compliance in diabetic versus nAMD patients.

Keyphrases

newly diagnosed
end stage renal disease
diabetic retinopathy
prognostic factors
age related macular degeneration
ultrasound guided